Figure 3
From: Safety, pharmacokinetics, and pharmacodynamics of milvexian in healthy Japanese participants
Percent change from baseline in aPTT versus milvexian plasma concentration. aPTT, activated partial thromboplastin time.
Figure 3 | Scientific Reports
